Atlas Trials

Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease

Clinical trial NCT02217345 · COMPLETED

Trial details

NCT number
NCT02217345
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonalcoholic Fatty Liver Disease (NAFLD)
Start date
2017-06-02
Primary completion
2021-08-10
Enrollment
131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.